The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119534207 11953420 7 F 20151209 20160810 20160126 20160818 EXP CA-JNJFOC-20160118009 JANSSEN 54.80 YR A F Y 71.50000 KG 20160818 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119534207 11953420 1 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 46 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 2 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 3 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 4 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 47 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 5 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 48 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 6 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 50 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 7 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 49 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 8 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 9 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 47 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 10 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 46 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 11 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 12 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 13 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 50 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 14 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 49 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 15 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) HAD 48 INFUSIONS N U FKM95012;FKM95011;GCM21013 +MORE 0 500 MG LYOPHILIZED POWDER
119534207 11953420 16 PS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) N U FKM95012;FKM95011;GCM21013 +MORE 103772 500 MG LYOPHILIZED POWDER
119534207 11953420 17 C MESALAMINE. MESALAMINE 1 Oral 6 TABLETS 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119534207 11953420 1 Crohn's disease
119534207 11953420 2 Crohn's disease
119534207 11953420 3 Crohn's disease
119534207 11953420 4 Crohn's disease
119534207 11953420 5 Crohn's disease
119534207 11953420 6 Crohn's disease
119534207 11953420 7 Crohn's disease
119534207 11953420 8 Crohn's disease
119534207 11953420 9 Colitis ulcerative
119534207 11953420 10 Colitis ulcerative
119534207 11953420 11 Colitis ulcerative
119534207 11953420 12 Colitis ulcerative
119534207 11953420 13 Colitis ulcerative
119534207 11953420 14 Colitis ulcerative
119534207 11953420 15 Colitis ulcerative
119534207 11953420 16 Colitis ulcerative

Outcome of event

Event ID CASEID OUTC COD
119534207 11953420 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
119534207 11953420 Anal squamous cell carcinoma
119534207 11953420 Diarrhoea
119534207 11953420 Drug ineffective
119534207 11953420 General physical health deterioration
119534207 11953420 Haematochezia
119534207 11953420 White blood cell count increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119534207 11953420 1 20151113 0
119534207 11953420 2 20100917 0
119534207 11953420 3 20090612 0
119534207 11953420 4 20160121 0
119534207 11953420 5 20160415 0
119534207 11953420 6 20160810 0
119534207 11953420 7 20160614 0
119534207 11953420 8 20070608 0
119534207 11953420 9 20160121 0
119534207 11953420 10 20151113 0
119534207 11953420 11 20100917 0
119534207 11953420 12 20070608 0
119534207 11953420 13 20160810 0
119534207 11953420 14 20160614 0
119534207 11953420 15 20160415 0
119534207 11953420 16 20090612 0